BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

SCHOTT PHARMA USA, INC. — Lobbying — Receipts Report

LD-2 disclosure · 4th Quarter - Report

SCHOTT PHARMA USA, INC.

via MICHAEL BEST STRATEGIES LLC

4th Quarter (Oct 1 - Dec 31) · 2023Posted Jan 23, 2024Filing document ↗LDA record ↗

Income$80Kfee reported

Client

Name: SCHOTT PHARMA USA, INC.
Description: manufacturing of medical-grade glass and polymer packaging for pharmaceuticals
Location: New York · United States of America

Registrant

Firm: MICHAEL BEST STRATEGIES LLC
Description: Government Relations Firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
Issues relating to opportunities to support healthcare supply chain.
LobbyistsSARAH HELTON · ALEXANDER ANGELSON · LUCIA ALONZO · BRETT EWER
Covered position (SARAH HELTON): Intern, House of Representatives
Covered position (ALEXANDER ANGELSON): Special Assistant to the President, White House Legislative Affairs
Covered position (BRETT EWER): Intern, Senate
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.